Fresenius Medical Care

Fresenius Medical Care Carbon Emissions and Climate Commitments

Fresenius Medical Care, a key player in the medical, precision, and optical instruments sector, is actively engaged in reducing its environmental impact. For the reporting year 2025, the company reported total emissions of approximately 3.87 billion kg CO2e. This figure comprises Scope 1 emissions of about 365.2 million kg CO2e, Scope 2 emissions (market-based) of roughly 284.4 million kg CO2e, and significant Scope 3 emissions totalling approximately 3.09 billion kg CO2e. The largest contributors within Scope 3 are purchased goods and services (about 1.49 billion kg CO2e) and the use of sold products (around 872.7 million kg CO2e).

The company has established clear climate targets. By 2030, Fresenius Medical Care aims to reduce its combined Scope 1 and Scope 2 market-based greenhouse gas (GHG) emissions by 50%, using 2020 as the base year. The 2020 baseline emissions for Scope 1 and 2 were approximately 915.7 million kg CO2e. Furthermore, the company has committed to achieving climate neutrality in its operations by 2040, aligning with the Paris Agreement goals.

To support these objectives, Fresenius Medical Care has also set near-term Scope 3 reduction targets. By 2030, it aims to decrease absolute Scope 3 emissions from fuel- and energy-related activities, business travel, and the use of sold products by 25%, relative to a 2024 baseline. Longer-term, the commitment extends to achieving net-zero GHG emissions across the entire value chain by 2050. As part of its Science Based Targets initiative (SBTi) commitments, the company also aims for 70% of its suppliers, by emissions, covering purchased goods and services, capital goods, and upstream transportation and distribution, to have science-based targets by 2030. Fresenius Medical Care's Scope 1 and 2 emissions have already seen a 16% reduction from their 2020 baseline.